by allowing intact igg to be used instead of fragments , a higher percentage of the radiolabeled anti-tumor antibodies may be concentrated in the tumor to provide higher tumor doses , yet toxicity to the normal tissues may be controlled by the removal of the radiolabeled antibody from the blood .
C0003251
tumor antibodies
C0003241
antibody